791626-58-9

Basic information

• Product Name: 6-BROMO-2-QUINAZOLINAMINE
• Synonyms: 6-BROMO-2-QUINAZOLINAMINE;6-BROMOQUINAZOLIN-2-AMINE;2-AMINO-6-BROMOQUINAZOLINE;6-BROMO-2-QUINOLINAMINE;2-Amino-6-bromoquinoline;6-Bromo-2-aminoquinoline;2-QuinolinaMine,6-broMo-;(6-Bromoquinolin-2-yl)amine≥ 97% (HPLC)
• CAS NO: 791626-58-9
• Molecular Formula: C₉H₇BrN₂
• Molecular Weight: 224.06
• Mol File: 791626-58-9.mol
• Article Data: 11

Chemical Properties

• Melting Point: 141-146 °C
• Boiling Point: 362.4 °C at 760 mmHg
• Flash Point: 173 °C
• Appearance: /
• Density: 1.649
• Vapor Pressure: 1.93E-05mmHg at 25°C
• Refractive Index: 1.732
• Storage Temp.: 2-8°C(protect from light)
• PKA: 5.83±0.43(Predicted)
• CAS DataBase Reference: 6-BROMO-2-QUINAZOLINAMINE(CAS DataBase Reference)
• NIST Chemistry Reference: 6-BROMO-2-QUINAZOLINAMINE(791626-58-9)
• EPA Substance Registry System: 6-BROMO-2-QUINAZOLINAMINE(791626-58-9)

Safety Data

• Hazardous Substances Data: 791626-58-9(Hazardous Substances Data)

Usage

Chemical Properties

Yellow to gray solid

InChI:InChI=1/C9H7BrN2/c10-7-2-3-8-6(5-7)1-4-9(11)12-8/h1-5H,(H2,11,12)

Upstream product

• 1810-71-5 6-bromo-2-chloroquinoline 
• 106-40-1 4-bromo-aniline 
• 1810-66-8 6-bromoquinoline-2-ol 
• 1312611-18-9 C₁₄H₁₅BrN₂O₂ 
• 65185-41-3 6-bromoquinoline-2-carbonitrile 
• 65148-10-9 6-bromo-quinoline-2-carboxylic acid 
• 6563-11-7 6-bromoquinoline-N-oxide 
• 5332-25-2 6-bromoquinoline 

Downstream Products

• 1312609-38-3 C₃₉H₃₇N₇O₄ 
• 1312611-23-6 C₃₆H₃₉N₇O₆ 
• 1312611-83-8 C₃₁H₃₁N₇O₄ 
• 1312611-24-7 C₃₉H₃₇N₇O₅ 
• 1312611-25-8 C₃₁H₃₁N₇O₃ 
• 1312609-34-9 C₃₈H₄₂N₈O₆ 
• 1312611-26-9 C₃₈H₄₂N₈O₇ 
• 1312609-41-8 C₃₈H₄₂N₈O₆ 
• 1312609-37-2 C₄₀H₃₈N₆O₄ 
• 1312611-34-9 C₃₇H₄₀N₆O₆ 
• 1312611-36-1 C₃₇H₄₀N₆O₅ 
• 1312611-86-1 C₃₂H₃₂N₆O₃ 
• 1312609-35-0 C₃₉H₄₃N₇O₆ 

Relevant articles and documents

PICOLINAMIDE DERIVATIVES USEFUL AS AGRICULTURAL FUNGICIDES

The present invention relates to picolinic acid derivatives that are useful in treating fungal diseases, particularly in plants.

HETEROARYL COMPOUNDS AS INHIBITORS OF NECROSIS, COMPOSITION AND METHOD USING THE SAME

The present disclosure provides heteroaryl compounds of Formula (I), processes for their preparation, pharmaceutical compositions containing them, and their use in the treatment of diseases and disorders, arising from or related to necrosis. Formula (I) is shown below:

Synthesis, photophysical and electrochemical properties of aza-boron-diquinomethene complexes

A series of aza-boron-diquinomethene (aza-BODIQU) complexes with different aryl-substituents (B1-B6) were synthesized and characterized. Their photophysical properties were investigated systematically via spectroscopic and theoretical methods. All complexes exhibit strong 1π-π* absorption bands and intense fluorescent emission bands in the visible spectral region at room temperature. The fluorescence spectra in solution show the mirror image features of the S0→S1 absorption bands, which can be assigned to the 1π-π*/1ICT (intramolecular charge transfer) emitting states. Except for B6, all complexes exhibit high photoluminescence quantum yields (ΦPL = 0.47-0.93). The spectroscopic studies and theoretical calculations indicate that the photophysical properties of these aza-BODIQUs can be tuned by the appended aryl-substituents, which would be useful for rational design of boron-fluorine complexes with high emission quantum yield for organic light-emitting applications.